Wednesday, July 30, 2014

IRMA-led Global Collaboration Supports Lubricant Advocacy Projects in Africa

Social marketing material developed by Centre for Popular Education and Human Rights, a 2014 GLAM grantee in Ghana

AVAC
, amfar, COC Netherlands and International Rectal Microbicide Advocates (IRMA) are pleased to announce seven Global Lube Access Mobilisation (GLAM) awards to projects in Africa.

GLAM, an initiative of IRMA’s Project ARM (Africa for Rectal Microbicides) in collaboration with amfAR, AVAC, and COC Netherlands, promotes advocacy in support of increased access to safe, condom-compatible lubricants for all Africans who engage in anal and vaginal intercourse, including GMT (gay men and other men who have sex with men, and transgender individuals) and heterosexual men and women.

In response to a request for proposals widely disseminated in February 2014, GLAM partners received 36 proposals representing 17 African countries (Botswana, Cameroun, Côte d’Ivoire, Democratic Republic of Congo, Ghana, Kenya, Lesotho, Malawi, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Togo, Uganda, Zambia and Zimbabwe). A diverse team of 20 advocates and public health professionals with an interest in lubricant access in Africa (from Nigeria, Uganda, Kenya, Zambia, Liberia, South Africa, Rwanda, Benin, Canada, Netherlands and the United States) reviewed the proposals.

Seven projects were selected for funding. These projects began in early July 2014 and will complete their efforts in December 2014. Following is a list of these projects.

Alternatives Cameroun (Douala, Cameroun)
Working in collaboration with other organizations in Douala and Yaoundé, Alternatives Cameroun plans to organize meetings and workshops with health officials and other HIV stakeholders in the country. The meetings and workshops will underscore the importance of providing safe, condom-compatible lubricant as part of comprehensive HIV and STI prevention programming. These activities support the ultimate goal of developing and securing a channel for the distribution of safe, condom-compatible lubricant throughout Cameroun.

Centre for Popular Education and Human Rights (Accra, Ghana)
Centre for Popular Education and Human Rights (CEPEHRG) will campaign to increase access, availability, and use of safe, affordable, condom-compatible lubricant by all who engage in sexual intercourse in Ghana, with special attention given to the LGBT community. The group will call for the inclusion of condom-compatible lubricant in the national essential drug list. Educational and social marketing efforts will take place at the community outreach level and through CEPEHRG’s national advocacy work.

Centre Stage Media Arts Foundation (Bulawayo, Zimbabwe)
Centre Stage Media Arts Foundation (CSMA) will convene policy advisory seminars to engage stakeholders from the Ministry of Health, legislators and members of civil society in support of three goals. One, integrate access to safe, condom-compatible lubricant in the Zimbabwe National HIV/AIDS Strategic Plan. Two, advocate for inclusion of lube as a line item in the national HIV prevention budget. Three, campaign for policy and program changes to allow for the distribution of lube through the same public health distribution channels that condoms are distributed through. A policy brief on the integration of lube access into national HIV prevention policies and programs will be produced. Traditional and social media will be utilized.

Community Health Education Services & Advocacy (Dar es Salaam, Tanzania)Securing government leadership and commitment to amend the national condom policy and include the provision of safe, condom-compatible lubricant in public health facilities is the chief goal of Community Health Education Services & Advocacy (CHESA). The group will work to build multi-sectorial awareness of the importance of lubricant and will engage the Minister of Health and Social Welfare, health care practitioners, community based organizations, as well as members of the GMT community. The public health message will be “Condom Compatible Lubricant Reduces New HIV Infections.”

Men Against AIDS Youth Group (Kisumu, Kenya)
Men Against AIDS Youth Group (MAAYGO) seeks to increase access to safe, condom-compatible lubricants through several methods. The group will conduct a needs assessment and implement a targeted advocacy campaign in Kisumu County for the GMT community, health care workers, and policy makers. Educational workshops will be conducted with the goal of developing a cadre of lube access advocates who will work to improve government policies and programs. A print/social marketing campaign highlighting the importance of lubricant access in HIV/STI prevention programming will be launched.

New HIV Vaccine and Microbicide Advocacy Society (Lagos, Nigeria)
The strategy New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) will take to improve lubricant access in Nigeria will be to create public demand for these important products for both men and women. Advocacy will be conducted at the state and national levels to promote government investment in lube access. NHVMAS will utilize its listserv, engage the media, and conduct trainings to enhance community awareness of the importance of safe, condom-compatible lubricant in HIV/STI prevention programming.

Partners in Health Research and Development (Thika, Kenya)
The work of Partners in Health Research and Development (PHRD) will seek to improve knowledge of and access to condoms and safe, condom-compatible lubricant among key populations in Kenya. In addition, the group will undertake actions in support of the establishment of a sustainable condom and lubricant delivery system. Sensitisation sessions will be conducted for stakeholders including HIV prevention advocates, civil society coalitions, policy makers, government officials, donors, condom distributors and the media. The inclusion of safe, condom-compatible lubricant in the National Strategic Plan is one of the project’s key projected milestones.


Related materials:

Click here for the GLAM Toolkit in English in French.

The GLAM initiative supported three African projects in 2013. Click here for a GLAM PowerPoint presentation that includes information on these projects.

Click here to access the Project ARM report, "On the Map: Ensuring Africa's Place in Rectal Microbicide Research and Advocacy", published in 2012.

-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

  *Also, please note that shared news items from other sources posted on this blog, Facebook, and Twitter do not necessarily mean IRMA has taken any position on the article's content.

  -------------------

Tuesday, February 4, 2014

Those Lube Stickers Aren’t Just For Show!

by Mike Wilson
(former IRMA intern, IRMA advocate forever)

 Hello IRMA! It feels like I have not said that greeting in ages. I may not be an intern with the AIDS Foundation of Chicago, but I have certainly not left behind my engagement with (and love of) IRMA and other HIV prevention organizations.

Since leaving the IRMA internship I have been working as a Youth Advocate for a teen center in the greater Chicago area. While I will honestly attest to the fact that working with the teens at the center and local community has been a rewarding experience, it has not come without its fair share of awkwardness - most notably the “pearl clutching” that occurs when people ask me what I did before working at the teen center.

And to be fair, it hasn’t all been “pearl clutching.” The community in this area is absolutely fantastic, I have been surprised time and time again at how committed this community is to its teens and families. And as my husband and I move to upstate New York, we can only hope that we find ourselves in a community as dedicated to the concept of community. Particularly among the teens there has been a surprising interest in discussing HIV prevention methods - so hopefully the seeds of future activism are being planted.

Along with this surprising interest, there has been confusion and silence as I get the feeling that many of the teens (and members of the community) are ignorant of the HIV/AIDS battle being fought not even a mile away in the city of Chicago. Though the mostly white, fairly wealthy families of this area are privileged enough to not be the face of the HIV/AIDS epidemic in Chicago, but within that privilege they often find themselves shut off from understanding how real and close this epidemic is. Perhaps the best way to explain this is by discussing what happened last weekend.

In an effort to get teens involved in volunteer work, our center leads monthly trips into Chicago to a soup kitchen to let the teens learn about experiences other than their own and to learn the importance of community engagement and volunteerism. These trips involve meeting at the center and then piling into the cars of various staff members.

However, this time, as I was closing up the center doors, teens had began to make their way into the parking lot. A group of four teens happened to notice a small blue Neon that has a few (too many) bumper stickers on the back. Interestingly enough, these teens didn’t know that this was my car. As I approached the group to let them in my car, I could hear them laughing and one of them saying “And Lube? And Lube? What the hell?” To which, the group continued to laugh more than I thought someone could at the concept of lubricant.

Not sure how to proceed I walked through the group and unlocked the car. There was this awkward pause as the teens looked at me, in shock that they were making fun of bumper stickers on a car that they didn’t know was mine. I opened my door to get in and the teens still stood, seeming hesitant. To which I just said, “well lube matters” and quickly followed that with “ok, now come on. We’re going to be late”. And they hurried into the car.

Even with the radio on, there was an awkward silence in the car. The teens were clearly worried that I may have been upset and I was attempting to figure out how to best explain that I wasn’t upset with them, but still reinforce some message about GLAM (Global Lube Access Mobilization) and the “And Lube” campaign.

Suddenly, the silence was broken. “So, uh, Mike... yeah... we weren’t making fun of your car. It’s just, having a sticker about lube isn’t something you see everyday”.

To which I laughed a bit. “Oh please, I wouldn’t care if you made fun of this car. I’m a grad student, of course my car isn’t wonderful.”

To which a teen perked up in his seat. “So what? Do the stickers hold the car together?” The teens laughed, I couldn’t help but join in a bit.

“More or less,” I responded. “And really guys, don’t worry about it.”

“So I have to ask, what does ‘And Lube’ mean?”

“Well, the ‘And Lube’ campaign is exactly what it sounds like. It’s about advocating for proper lubricant along with condoms in the fight against HIV/AIDS.”

“Why would you need that?”

“Well, as I’m sure you’ve discussed in health classes. Condoms can break, or slip, or tear. And that can make them problematic for HIV/AIDS prevention. Having proper lubricant along with condoms helps prevent those issues and thus helps to prevent new HIV infections.”

And then the most wonderful reply came: “makes sense.”

There were many ways that I could have handled this situation. My first instinct, honestly, was to just say something along the lines of “lube access isn’t funny,” but I didn’t want to come across as overly judgmental. And in all honesty, before I worked with IRMA, I don’t think I would have thought any differently than this group of teens that I already know are well-engaged.

Yes, this situation may have been awkward at first. But it was a great opportunity to explore that awkwardness and get in some activism. It is surprising how much a sticker can get someone talking and it is even more surprising to see someone engage with that humor and to then be reminded that activism is about education and engagement after all.



-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

  -------------------

Wednesday, October 2, 2013

Advocates Applaud Launch of MTN-017, World’s First Phase II Rectal Microbicide Study

[IRMA press release]
 
Trial Design Significantly Enhanced By Strong Community Input

October 2, 2013 – IRMA applauds the launch of the world’s first-ever Phase II rectal microbicide trial. The Microbicide Trial Network’s study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally. Volunteers consisting of gay men, other men who have sex with men, and transgender women will participate in the study at sites in the United States and in Thailand, South Africa, and Peru.

“Today feels like every holiday imaginable rolled into one,” said Jim Pickett, chair of International Rectal Microbicide Advocates (IRMA.) “The launch of the MTN-017 study is a milestone long in the making and marks a giant leap forward in the development of safe, effective, acceptable, and accessible products that could be used to prevent HIV during anal intercourse.”

IRMA is pleased to have participated in an intensive community input process with the Microbicide Trials Network that included in-person consultations with advocates and key stakeholders in Thailand, South Africa, Peru and the United States. “The dreams and desires of many men, women, and transgender individuals the world over can be heard loud and clear in the design of the MTN-017 trial. This deep collaboration between scientists and community members is key to the success of this trial and to the rectal microbicide field in general,” said Pickett.

When microbicides were first imagined, they were “vagina-centric.” While many embraced the notion of creating vaginal products women could control, the majority of the HIV/AIDS community— scientists and advocates alike— dismissed the possibility of developing rectal microbicides for use during anal intercourse as an HIV prevention method. It was not considered feasible and the pursuit was seen as hopeless, even laughable. At best, the rectal microbicide field would consist of testing vaginal microbicides for rectal safety, because these products would undoubtedly end up in the rectum despite their intended destination.

IRMA thanks the visionary scientists, advocates and funders like the U.S. National Institutes of Health who bucked prevailing “wisdom” and have remained steadfast in their commitment to developing new HIV prevention methods for use during anal intercourse.

“I feel like we are taking two giant leaps forward today. One in the fight against HIV, and the other in the fight against ignorance and small thinking,” said Pickett.

# # # #

International Rectal Microbicide Advocates (IRMA) is a global network, housed at AIDS Foundation of Chicago, comprised of more than 1,200 advocates, scientists, policy makers and funders focused on rectal microbicide research and advocacy and related issues such as access to safe, condom-compatible lubricants.

Learn more about the MTN-017 study here.

Watch this video “The Rectal Revolution is Here: An introduction to rectal microbicide clinical trials” in English, Spanish, or Thai.

-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

-------------------

Sunday, September 8, 2013

Sept 10 at #USCA2013 - Everything You Need to Know About #Anal Health

This Tuesday, September 10 at the United States Conference on AIDS in New Orleans join IRMA and friends from 4:30 p.m. to 6 p.m. for this fun workshop on anal health and rectal microbicide research and advocacy.

Session 5: Imperial 9, Level 4. See ya there - show your rectal pride!


-------------------

 *Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

 *Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

 -------------------

Monday, July 15, 2013

Adherence to rectal microbicide use among mainly ethnic minority young MSM: lessons from a 3-month placebo gel trial at three US sites [IAS 2013]

Oral paper presented by Alex Carballo-Diéguez at IAS 2013.

 

Abstract:

Background: Adherence to product use is the cornerstone of microbicide studies. This is the first study to assess how frequently mainly ethnic minority MSM, ages 18-30, with a history of unprotected receptive anal intercourse (RAI) in the prior year, would self-administer gel using a rectal-specific applicator prior to RAI in their everyday lives.

Methods: Recruitment took place in Boston, MA; Pittsburgh, PA, and San Juan, PR. Participants received 40 applicators prefilled with 4mL of hydroxyethylcellulose placebo gel that they could use over 12 weeks. They were asked to self-administer a dose within 90 minutes prior to RAI and report RAI and gel use at least weekly through an interactive voice response system (IVRS). At week 12, they responded to a Computer Assisted Self Interview (CASI) and underwent an in-depth interview. Participants were repeatedly counseled that the study focused on product adherence and that the gel would not protect against HIV.

Results: 124 MSM were enrolled (Mean age 23.1; 41% White, 40% Latino, 8% African American, 11% mixed/other). 95 participants completed the trial (18 were lost to follow up and 11 withdrew). Based on the IVRS, (n=94, 1 missing data), 88 participants had RAI (Median 10 occasions) using gel on 81.1% of occasions (SD 23.3, range 0-100). Based on CASI, (n=86, 9 refused to answer RAI question) 83 participants had RAI (Median 12 occasions) using gel on 81.7% of occasions (SD 26.7; 0-100). Based on CASI, 69% of men typically applied gel immediately before RAI; 40 inconsistent users gave as reasons not having gel with them (85%), forgetting to use it (48%), not wanting to use it (13%), partner refusal (10%) and gel messiness (10%).

Conclusions: Ethnically diverse young MSM with a history of unprotected RAI showed high adherence to gel use. Adherence to product use could potentially be enhanced by improving portability, facilitating the development of routines to counteract forgetfulness, and improving motivation and partner negotiation skills. Participant retention was challenging and needs further study. Two different self-report methods provided convergent results. Limitation: A product of known efficacy could have different uptake than the placebo used in this study.


Click for slides.

 
-------------------

*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,200 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

  -------------------
Related Posts Plugin for WordPress, Blogger...